Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with O
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q3 2024 | OPADRY YS-1-13148A ORANGE | ORAL | TABLET | 10.00 mg | 10mg | Deletion | |
| Q3 2024 | OPADRY YS-1-7444G WHITE | ORAL | TABLET, COATED | 22.00 mg | Deletion | ||
| Q2 2024 | OPADRY AMB OY-B-28920 WHITE | ORAL | TABLET | 2.50 mg | MDE Replacement | ||
| Q3 2024 | OPADRY AMB OY-B-28920 WHITE | ORAL | TABLET | 24mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024